JFG
GSK icon

Jefferies Financial Group’s GSK GSK Stock Holding History

Jefferies Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,825
Closed -$678K – 1931
2025
Q4 		$678K Buy
+13,825
New +$645K ﹤0.01% 1243
2023
Q4 		– Sell
-23,503
Closed -$852K – 1805
2023
Q3 		$852K Buy
+23,503
New +$834K 0.01% 881
2023
Q1 		– Sell
-6,314
Closed -$222K – 1757
2022
Q4 		$222K Buy
+6,314
New +$210K ﹤0.01% 1275

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jefferies Financial Group's GSK Position: Q1 2026 in Review

Jefferies Financial Group sold out of GSK (GSK) in Q1 2026, closing a stake of 13,825 shares — an estimated $678K sold.

Jefferies Financial Group first reported a position in GSK in Q4 2022 and held it in 3 quarters. The position peaked at $852K in Q3 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Jefferies Financial Group reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 13,825 GSK shares in Q1 2026, an estimated $678K.
  • Jefferies Financial Group first reported a position in GSK in Q4 2022 and held it in 3 quarters.
  • Jefferies Financial Group's GSK position peaked at $852K in Q3 2023.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.